About US
Contact us
-
India yanks Takeda's Actos on safety concernsWhy now? That's a fair question aboutIndia'smove to suspend the sale of three drugs, includingTakeda Pharmaceuticals'now-off-patent blockbuster,Actos. The country's health ministry also banned Analgin2013/6/27
-
Bayer, Boehringer eye big growth in expanding anticoagulant marketBlood-clot fighters are expected to grow faster than any other drugs over the next 6 years. Here are two reasons why: The U.K.'s cost-effectiveness watchdog gave final clearance toBayer'santicoagulant2013/6/27
-
Allergan hits skids on probability of early Restasis genericsAllergan is eyeing some earlygeneric competitionfor its $792 million drug Restasis. The FDA says it won't need a clinical trial for approval of copycat versions, meaning the treatment for chronic dry2013/6/26
-
Merck wins Indian injunction against Januvia copycatsMerck's ($MRK)Indianunit won an injunction in a patent fight over its diabetes drugsJanuviaandJanumet, blocking generic versions of the two drugs to be made by Indian drugmaker Aprica Pharmaceuticals.2013/6/26
-
Top-prescribing docs collect cash from drugmakersDoctors who prescribe certain brands the most also have financial ties to the companies that make them, aProPublicainvestigation found. Coincidence? Experts think not. Using Medicare payment data,Pro2013/6/25
-
Eisai pulls Fycompa in Germany to protest pricingEisaiis fed up withGermany'spricing authority. The Japanese drugmaker is so fed up, in fact, that it plans to stop selling its new seizure drug there. It's just the latest example of a pharma company2013/6/25
-
U.K. looks to slash branded drug prices up to 20%Government looking at cuts to drugs that fall outside PPRS Makersof branded drugs have been fighting a rising tide of price pressure in the U.K. and Europe, where protectors of government health plan2013/6/24
-
EU grants U.S. API makers exemption from certification ruleThe FDA has gotten the coveted waiver from the European Commission from its new rules for imported APIs less than two weeks before the rule is set to go into effect on July 2. It means that APIs manuf2013/6/24
-
Official stresses joint efforts to ensure food safetyChinese Vice Premier Wang Yang has called for combined efforts including enterprises' self-discipline, government supervision and public scrutiny to promote food safety in the country. Wang made the2013/6/20
-
AMA's obesity ruling could inspire new drug effortsThe AMA's decision to classifyobesityas a disease is a direct attempt to persuade biopharma companies to develop new therapies by making it harder for payers to decline coverage while applying pressur2013/6/20